Nanosonics Sponsors Educational Symposium on Standardizing Ultrasound Probe Disinfection Practices at APIC 2019
Showcases automated trophon2 complete reprocessing solution for
optimized probe decontamination
PHILADELPHIA–(BUSINESS WIRE)–#APIC2019—Nanosonics
(ASX: NAN), a leader in infection prevention solutions, will highlight
its proprietary automated trophon®2
complete ultrasound reprocessing system and sponsor an educational
breakfast symposium on standardizing ultrasound probe reprocessing
during the 2019 APIC,
June 12-14 in Philadelphia.
The symposium,
entitled “Standardizing Ultrasound Probe Reprocessing: The Ultrasound
Infection Prevention (IP) Toolkit,” will be presented by Robert Garcia,
a senior infection preventionist, researcher and consultant for nearly
40 years, and Betty McGinty, a medical device reprocessing expert and
quality director for a major healthcare system in Atlanta. The focus
will be implementing and supporting reliable and effective reprocessing
of probes throughout hospitals with special emphasis on recent research,
federal guidelines and the successful application of the Ultrasound
IP Toolkit.
The Ultrasound IP Toolkit was developed by industry experts to help
users meet existing evidence-based guidelines and standards. The toolkit
can assist departments, facilities or entire healthcare systems
systematically standardize their ultrasound infection prevention
practices.
“As the rapid increase of ultrasound imaging presents potential
infection control challenges throughout hospitals, appropriate education
is crucial to maintaining patient safety and minimizing infection
transmission,” said Rose Seavey, president of Seavey Healthcare
Consulting and a device reprocessing expert involved in the development
of national standards. Seavey is also a member of the expert group
behind the development of the Ultrasound IP Toolkit.
“There are areas of procedure awareness that need to be explored and
addressed, including the application of high-level disinfection (HLD) to
surface ultrasound transducers used in invasive procedures in accordance
with Spaulding,” continues Seavey. “The Ultrasound IP Toolkit was
created by a group of concerned infection preventionists and
reprocessing experts to offer a valuable educational resource designed
to help facilities standardize their ultrasound disinfection practices,
create policy and more effectively prevent infections.”
Ruth M. Carrico, Associate Professor, Division of Infectious Diseases,
University of Louisville School of Medicine, Ky., and Garcia will
present their findings from a recent survey of IPs regarding a variety
of disinfection and use practices for ultrasound probes during APIC’s
Educational Session #3204. In addition, an observational study on the
use and reprocessing of probes in interventional procedures will be
presented.
“In addition to highlighting important resources and strategies for
evidence-based advances in ultrasound infection prevention, we’re
excited to showcase trophon2 at the annual APIC conference, the largest
gathering of infection prevention professionals worldwide,” said Ken
Shaw, president of North America for Nanosonics. “Our latest innovation
in HLD for probes, trophon2 is widely considered the new standard of
care offering a complete automated reprocessing solution that is proven
to be effective against a wide range of pathogens while helping ensure
compliance with the latest guideline requirements.”
During the APIC annual conference, industry experts will be stationed in
Nanosonics’ booth #709 discussing the Ultrasound IP Toolkit as well as
Nanosonics’ HLD
solution. Interactive stations will feature probe compatibility and
the robust testing process that they go through along with trophon
AuditPro, a new data management service for compliance reporting and
audit readiness.
About trophon* Technology
Nanosonics’ trophon*
technology’s high-frequency ultrasonic vibrations generate a sonically
activated, supercharged hydrogen peroxide (H2O2)
mist that inactivates drug resistant pathogens and spores that cause
sexually transmitted infections (STIs) such as Gonorrhea, HIV and
high-risk Human Papillomaviruses (HPV),1
as well as drug resistant bacteria including MRSA. The trophon systems
are installed in more than 4,000 hospitals and facilities in North
America including all of the top 50 U.S. hospitals** and it’s estimated
that trophon technology is protecting over 60,000 patients daily from
the risks of cross-contamination. The device is validated for use with
over 1,000 probes.
About Nanosonics
Nanosonics
(ASX:NAN) is a leading medical technology company headquartered in
Sydney, Australia, with its North American operations based in
Indianapolis. Founded in 2001, the company is one of Australia’s largest
medical technology companies and a recognized leader in its sector of
the global infection control market. More information may be found at www.nanosonics.us
Note to Editors:
Standardizing Ultrasound Probe Reprocessing
Breakfast Symposium
To register: https://info.nanosonics.com.au/apic2019
Friday,
June 14, 2019
6:00 – 7:30 AM
Room 204 AB
Philadelphia
Convention Center
*trophon [trophon EPR & trophon2]
1. Ryndock E, Robison R,
Meyers C. Susceptibility of HPV16 and 18 to high level disinfectants
indicated for semi-critical ultrasound probes. J Med Virol.
2016;88(6):1076-80.
**US News and World Report.
Contacts
Amy Cook
amy@amcpublicrelations.net
https://www.nanosonics.us/news/media-kit/
